US NUCLEAR CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-22: Form 8-K; Period of report 2026-04-22; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2025-11-05: Form 8-K/A; Period of report 2025-11-05; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2025-11-04: Form 8-K; Period of report 2025-11-04; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2024-12-20: Form 8-K; Period of report 2024-12-19; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2026-04-22 | 8-K | 2026-04-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On April 16, 2026, Michael Pope notified the Company of his decision to resign as a member of the Board of Directors of the Company. | ea0287360-8k_usnuclear.htm |
| 2025-11-05 | 8-K/A | 2025-11-05 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On October 29, 2025, US Nuclear Corp (the “Company”), through action of the Board of Directors of the Company, dismissed Fruci & Associates II, PLLC (“Fruci”) as the Company’s independent registered public accounting firm, effective as of October 29, 2025. | ea0264216-8ka_usnuclear.htm |
| 2025-11-04 | 8-K | 2025-11-04 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On October 29, 2025, US Nuclear Corp (the “Company”), through action of the Board of Directors of the Company, dismissed Fruci & Associates II, PLLC (“Fruci”) as the Company’s independent registered public accounting firm, effective as of October 29, 2025. | ea0263829-8k_usnuclear.htm |
| 2024-12-20 | 8-K | 2024-12-19 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective October 6, 2023, Michael Pope was appointed as a director of the Company. | ea0225437-8k_usnuclear.htm |
| 2024-12-12 | 8-K | 2024-12-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective October 6, 2023, Michael Pope was appointed as a director of the Company. | ea0224515-8k_usnuclear.htm |
| 2023-10-10 | 8-K | 2023-10-10 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective October 6, 2023, Michael Pope was appointed as a director of the Company. | ea186581-8k_usnuclear.htm |
| 2023-08-18 | 8-K | 2023-08-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On August 12, 2023, Richard Landry resigned from his position as our Chief Financial Officer. | ea183842-8k_usnuclear.htm |
| 2022-06-30 | 8-K | 2022-06-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 30, 2022, US Nuclear Corp, a Delaware corporation (the “Company”) received notice of resignation by its Chief Financial Officer, Rachel Boulds. | ea162332-8k_usnuclear.htm |
| 2022-05-16 | 8-K | 2022-05-16 | 1.01 Entry into a Material Definitive Agreement | 1.01 On May 5, 2022, US Nuclear Corp., a Delaware corporation (the “Corporation”) closed on a Securities Purchase Agreement (the “SPA”) with Mast Hill Fund, L.P., providing for the issuance of the promissory note in the principal amount of $750,000.00, convertible into shares of the common stock at a fixed price of $0.20 per share, and cash warrants with $0.75 strike price. | ea160008-8k_usnuclear.htm |
| 2021-01-06 | 8-K | 2021-01-06 | 8.01 Other Events | 8.01 On November 25, 2019, US Nuclear Corp., a Delaware corporation (the “Corporation”) closed on a Securities Purchase Agreement (the “SPA”) with YA II PN, Ltd., a Cayman Islands limited company (“YA”). | ea132843-8k_usnuclearcorp.htm |
| 2020-05-14 | 8-K | 2020-05-14 | 8.01 Other Events | 8.01 US Nuclear Corp. (the “Company,”) files this Current Report on Form 8-K (“Report”) in reliance on the Securities and Exchange Commission (“SEC”) order dated March 25, 2020, Release No. 34-88465. | ea121718-8k_usnuclear.htm |
| 2020-03-30 | 8-K | 2020-03-30 | 8.01 Other Events | 8.01 US Nuclear Corp. (the “Company”) files this Current Report on Form 8-K (“Report”) in reliance on the Securities and Exchange Commission (“SEC”) order dated March 25, 2020, Release No. 34-88465. | ea120133-8k_usnuclear.htm |
| 2020-02-05 | 8-K | 2020-02-05 | 1.01 Entry into a Material Definitive Agreement | 1.01 On February 5, 2020, US Nuclear Corp., a Delaware corporation (the “Corporation”) entered into a Stock Purchase Agreement (“SPA”) with Grapheton, Inc., a California corporation (“Grapheton”). | ucle8k.htm |
| 2019-12-02 | 8-K | 2019-12-02 | 1.01 Entry into a Material Definitive Agreement | 1.01 On November 25, 2019, US Nuclear Corp., a Delaware corporation (the “Corporation”) closed on a Securities Purchase Agreement (the “SPA”) with YA II PN, Ltd., a Cayman Islands limited company (“YA”). | ucle8k.htm |
| 2019-06-14 | 8-K | 2019-06-10 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Dismissal of Independent Registered Public Accounting Firm. | f8k061019_usnuclear.htm |
| 2019-05-30 | 8-K | 2019-05-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 27, 2019, US Nuclear Corp., Delaware corporation (the “Company”) appointed Richard Landry as Chief Operating Officer, Director of Investor Relations, and Business Development Consultant. | f8k053019_usnuclearcorp.htm |
| 2018-07-02 | 8-K | 2018-06-05 | 1.01 Entry into a Material Definitive Agreement | 1.01 On June 5, 2018, US Nuclear Corp. and MIFTEC signed a definitive agreement which formally appoints US Nuclear as the exclusive manufacturer of MIFTEC’s medical isotope generators for North America and Asia, and makes US Nuclear a sales representative for all MIFTEC products. | form8k.htm |
| 2018-06-08 | 8-K | 2018-05-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Mr. Williamson began his career at Overhoff Technology Corporation (“Overoff”) in 1982. | form8k.htm |
| 2018-04-30 | 8-K | 2018-04-19 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.03 On April 19, 2018, the Board of Directors for US Nuclear Corp. (the “Company”) consented to the adoption of amendments to its Bylaws (the “Amended Bylaws”). 8.01 On April 19, 2018, the Board of Directors for the Company consented to the adoption of the US Nuclear Insider Trading Policy (the “Policy”). | ucle8k.htm |
| 2017-02-17 | 8-K/A | 2016-06-29 | 8.01 Other Events | 8.01 On June 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (the “Company”), authorized a private offering of restricted shares of its common stock to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. | ucle8ka20170217_0949.htm |
| 2016-12-14 | 8-K/A | 2016-12-14 | 8.01 Other Events | 8.01 On June 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (the “Company”), authorized a private offering of restricted shares of its common stock to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. | ucle8ka201612131818.htm |
| 2016-09-02 | 8-K/A | 2016-06-28 | 8.01 Other Events | 8.01 On June 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (the “Company”), authorized a private offering of restricted shares of its common stock to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. | ucle8ka20160902.htm |
| 2016-08-30 | 8-K/A | 2016-06-28 | 8.01 Other Events | 8.01 On June 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (the “Company”), authorized a private offering of restricted shares of its common stock to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. | ucle8ka20160826.htm |
| 2016-06-29 | 8-K | 2016-06-28 | 8.01 Other Events | 8.01 On June 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (the “Company”), authorized a private offering of restricted shares of its common stock to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. | ucle8kppm20160628_v2.htm |
| 2016-03-01 | 8-K | 2016-02-05 | 1.01 Entry into a Material Definitive Agreement | ucle8ksncl20160301v2.htm | |
| 2016-02-01 | 8-K | 2016-01-29 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 1.01 On January 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (hereinafter, the “Company”) entered into a series of resolutions ratifying and approving certain actions of the Company (hereinafter, the “Resolutions”). 5.02 On January 28, 2016, the Board of Directors for US Nuclear Corp., a Delaware corporation (hereinafter, the “Company”) entered into a series of resolutions ratifying and approving certain actions of the Company (hereinafter, the “Resolutions”). 8.01 In addition to the resolution related to the Entine Agreement, above, the Board of Directors ratified other prior actions of the Company. | usnu8kent20160131v2.htm |
| 2015-12-02 | 8-K | 2015-12-02 | 7.01 Regulation FD Disclosure | 7.01 Representatives of US Nuclear Corp. will use the investor presentation (the “Investor Presentation”) attached hereto as Exhibit 99.2 with various meetings with investors from time to time. | usn8k12215.htm |
| 2015-11-24 | 8-K | 2015-11-23 | 1.01 Entry into a Material Definitive Agreement | 1.01 On November 23, 2015, the majority shareholder, who is also the President, CEO and Chairman of the Board of Directors of the Registrant approved to engage Tech Associates Inc. as its corporate advisor. | usnuclear8k.htm |
| 2015-05-29 | 8-K | 2015-05-28 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Dismissal of Independent Registered Public Accounting Firm. | usnc8kitem401.htm |
| 2014-12-17 | 8-K/A | 2014-05-06 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Dismissal of Independent Registered Public Accounting Firm. | usnc8k562014.htm |
| 2014-10-17 | 8-K | 2014-10-16 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 16, 2014, Darian B. Andersen resigned as Chief Financial Officer and Secretary of US Nuclear Corp. (the “Company”), effective on October 31, 2014. | usnuclear101614.htm |
| 2014-05-13 | 8-K/A | 2014-05-06 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Dismissal of Independent Registered Public Accounting Firm. | usnc8k562014.htm |
| 2014-05-07 | 8-K | 2014-05-06 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) Dismissal of Independent Registered Public Accounting Firm. | usnc8k562014.htm |
| 2014-04-01 | 8-K | 2014-03-28 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 28, 2014, the Board of Directors (the “Board”) of US Nuclear Corp. (the “Company”) elected Dr. Gerald Entine to serve as a member of the Board, effective immediately. | usnuclear8k.htm |
| 2014-03-28 | 8-K | 2014-03-28 | 7.01 Regulation FD Disclosure | 7.01 Representatives of US Nuclear Corp. will use the investor presentation (the “Investor Presentation”) attached hereto as Exhibit 99.1 with various meetings with investors from time to time. | usnc8k.htm |
| 2014-01-03 | 8-K | 2014-01-01 | 3.02 Unregistered Sales of Equity Securities | 3.02 On January 1, 2014, the Registrant sold an aggregate of 450,000 shares of its common stock for aggregate consideration of $45 (a per-share price of $.0001, being the par value of the shares). | usnc8k1114.htm |
| 2013-12-31 | 8-K/A | 2013-10-14 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.01 Changes in Control of Registrant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.06 Change in Shell Company Status | 1.01 On October 15, 2013, US Nuclear Corp f/k/a APEX 3 Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger between the Company, Robert I. Goldstein, US Nuclear Acquisition Corp ("Merger Sub"), a California corporation and Optron Scientific Company, Inc. dba Technical Associates, ("Optron Scientific") a California corporation and the parent company of Overhoff Technology Corp. The Agreement and Plan of Merger provided for the acquisition by the Company of all of the outstanding shares of Optron Scientific through a reverse merger of Merger Sub into Optron Scientific, the surviving corporation. 2.01 As described above under Item 1.01, the Company entered into an Agreement and Plan of Merger with Optron Scientific Company, Inc, the parent company of Overhoff Technology Corp and Technical Associates, with the Company as the surviving corporation. 5.03 On October 15, 2013 the Registrant filed its Agreement and Plan of Merger with the State of California. | usnc8k10162013.htm |
| 2013-12-19 | 8-K/A | 2013-10-14 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.01 Changes in Control of Registrant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.06 Change in Shell Company Status | 1.01 On October 15, 2013, US Nuclear Corp f/k/a APEX 3 Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger between the Company, Robert I. Goldstein, US Nuclear Acquisition Corp ("Merger Sub"), a California corporation and Optron Scientific Company, Inc. dba Technical Associates, ("Optron Scientific") a California corporation and the parent company of Overhoff Technology Corp. The Agreement and Plan of Merger provided for the acquisition by the Company of all of the outstanding shares of Optron Scientific through a reverse merger of Merger Sub into Optron Scientific, the surviving corporation. 2.01 As described above under Item 1.01, the Company entered into an Agreement and Plan of Merger with Optron Scientific Company, Inc, the parent company of Overhoff Technology Corp and Technical Associates, with the Company as the surviving corporation. 5.03 On October 15, 2013 the Registrant filed its Agreement and Plan of Merger with the State of California. | usnc8k10162013.htm |
| 2013-11-14 | 8-K/A | 2013-10-14 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.01 Changes in Control of Registrant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.06 Change in Shell Company Status | 1.01 On October 15, 2013, US Nuclear Corp f/k/a APEX 3 Inc, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger between US Nuclear Acquisition Corp. (“Merger Sub”) and Optron Scientific Company, Inc., dba Technical Associates, the parent company of Overhoff Technology Corp. Under this agreement, US Nuclear Corp acquired Optron Scientific, a California corporation, and the shareholders of Optron Scientific received common stock in US Nuclear Corp, in exchange for their shares in Optron Scientific. 2.01 As described above under Item 1.01, the Company entered into an Agreement and Plan of Merger with Optron Scientific Company, Inc, the parent company of Overhoff Technology Corp and Technical Associates, with the Company as the surviving corporation. 5.03 On October 15, 2013 the Registrant filed its Agreement and Plan of Merger with the State of California. | usnc8k10162013.htm |
| 2013-10-17 | 8-K | 2013-10-14 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.06 Change in Shell Company Status | 1.01 On October 15, 2013, US Nuclear Corp f/k/a APEX 3 Inc, a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger with Optron Scientific Company Inc, (“Optron”) the parent company of Overhoff Technology Corp and Technical Associates. 2.01 As described above under Item 1.01, the Company entered into an Agreement and Plan of Merger with Optron Scientific Company, Inc, the parent company of Overhoff Technology Corp and Technical Associates, with the Company as the surviving corporation. 5.03 On October 15, 2013 the Registrant filed its Agreement and Plan of Merger with the State of Delaware. | usnc8k10162013.htm |
| 2013-10-17 | 8-K/A | 2013-10-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 15, 2013, the Registrant accepted the resignation of Robert Goldstein as the Registrant’s Chief Financial Officer and Secretary . | usnc8k101513.htm |
| 2013-10-15 | 8-K | 2013-10-15 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 15, 2013, the Registrant accepted the resignation of Robert Goldstein as the Registrant’s Chief Financial Officer. | usnc8k101513.htm |
| 2013-08-16 | 8-K | 2013-08-15 | 3.02 Unregistered Sales of Equity Securities | 3.02 On August 15, 2013, the Registrant sold an aggregate of 700,000 shares of its common stock for aggregate consideration of $70 (a per-share price of $.0001, being the par value of the shares). | usnc8152013.htm |
| 2013-04-01 | 8-K | 2013-03-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 31, 2013, the Registrant accepted the resignation from Richard Chiang as a member of the Board of Directors. | usn8k412013.htm |
| 2012-05-29 | 8-K | 2012-05-04 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.03 On May 4, 2012 the Registrant filed a Certificate of Amendment to the Articles of Incorporation with the Secretary of State of the State of Delaware to change the name of the Registrant to US Nuclear Corp. The foregoing description of the Amendment to the Articles of Incorporation is qualified in its entirety by reference to the text of the Amendment attached as Exhibit 3.3 to this Current Report on Form 8-K and incorporated herein by reference. | apex3_8kitem503.htm |
| 2012-05-22 | 8-K | 2012-05-18 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers. | apex3inc_8kchiangappointment.htm |
| 2012-04-24 | 8-K | 2012-04-18 | 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.01 On April 18, 2012, our sole officer and director, Richard Chiang entered into a Share Purchase Agreement pursuant to which he sold an aggregate of 10,000,000 shares of his shares of the Registrant’s common stock to US Nuclear Corp at a purchase price of $30,000. 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers. | apex3inc_8k.htm |